Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-20

Clinical Trial Update: NAC Trial for Anosmia [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating N-acetylcysteine for anosmia has completed. The study was sponsored by the University of Miami.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Miami | Conditions: Anosmia | EARLY_Phase 1 | Status: COMPLETED